United States News All stories

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said ENHERTU significantly improved progression-free survival versus standard first-line treatment in the Phase III DESTINY-Lung04 lung cancer trial.

Santacruz Silver Mining (NASDAQ:SCZM) reported Q2 2026 revenue of $113.5 million, up 55%, while gross profit doubled to $51.1 million.

Madison Air Solutions (NYSE:MAIR) agreed to acquire German airflow technology provider ebm-papst for a $5.4 billion enterprise value, or an effective $5 billion purchase price after expected tax savings.

Perpetua Resources (NASDAQ:PPTA) reported a Q2 2026 net loss of $97.5 million, versus $6 million a year earlier, as exploration and pre-development spending increased.

IM Cannabis (NASDAQ:IMCC) executed a definitive agreement on August 16, 2026, to sell all shares of I.M.C. Holdings to Slil.com Holding to clear up to C$9.4 million in liabilities.

H World Group (NASDAQ:HTHT) reported Q2 2026 revenue of RMB7.1 billion, up 10.8% year-over-year, while hotel turnover increased 13.2% to RMB30.5 billion.

TTM Technologies (NASDAQ:TTMI) agreed to acquire Epiq Design Solutions for approximately $1.1 billion in cash to expand its integrated electronics portfolio.

KBR (NYSE:KBR) secured a five-year NATO time-and-materials recompete contract with an initial $60 million ceiling to support the PATRIOT air and missile defense system.

Evolution Metals & Technologies (NASDAQ:EMAT) reported Q2 2026 revenue of $1.6 million and a $0.1 million gross loss as it expanded its non-China rare earth magnet operations.

Zai Lab (NASDAQ:ZLAB) and argenx (NASDAQ:ARGX) reported that VYVGART Hytrulo met the Phase 3 ALKIVIA primary endpoint with a 15.4-point TIS advantage over placebo at Week 52.

Centene (NYSE:CNC) named Chris Neczypor as its next CFO from January 1, 2027, while reaffirming 2026 adjusted diluted EPS guidance above $4.80.

ArcelorMittal (NYSE:MT) said a missile strike hit its Kryvyi Rih steel operation in Ukraine, killing two people, injuring 13 and partially halting production.

HUTCHMED (NASDAQ:HCM) reported that ORPATHYS plus TAGRISSO significantly improved progression-free and overall survival versus platinum-based chemotherapy in its 338-patient Phase 3 SAFFRON trial.

Mesoblast (NASDAQ:MESO) completed treatment of 350 patients in its pivotal Phase 3 MSB-DR004 trial of rexlemestrocel-L for chronic low back pain caused by degenerative disc disease.

Endeavour Silver (NYSE:EXK) temporarily suspended operations at its Terronera silver-gold mine in Jalisco, Mexico, after a community blockade began on August 12.

Genco Shipping & Trading (NYSE:GNK) defended its $27.50-per-share cash framework after Diana Shipping (NYSE:DSX) withdrew its offer to acquire the remaining Genco shares.

argenx (NASDAQ:ARGX) reported that subcutaneous VYVGART Hytrulo met the Phase 3 ALKIVIA primary endpoint, producing a 15.4-point greater mean Total Improvement Score than placebo at Week 52.

HIVE Digital Technologies (NASDAQ:HIVE), through BUZZ High Performance Computing, signed a five-year GPU cloud services agreement worth approximately $350 million with an investment-grade enterprise customer.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said Enhertu significantly improved progression-free survival versus standard first-line treatment for advanced HER2-mutant non-small cell lung cancer.

• Cisco Systems (NASDAQ:CSCO) reported FY 2026 revenue of $63.3 billion, up 12%, as AI infrastructure orders reached $9.3 billion.
• Arista, HPE, Dell and Ciena are also reporting higher networking or AI infrastructure sales as data-center spending expands.
• The next phase depends on sustained AI infrastructure demand, product execution, supply availability and competition across networking architectures.

• Super Micro Computer (NASDAQ:SMCI) reported fiscal Q4 2026 net sales of $11.1 billion, up about 91% year over year, driven by demand for AI server infrastructure.
• The company reported net income of $1.18 billion, a gross margin of 17.5%, and fiscal 2026 sales of $39.1 billion.
• AI infrastructure companies are expanding production capacity while managing supply constraints, capital requirements, and demand for high-performance computing systems.

• CoreWeave (NASDAQ:CRWV) reported Q2 2026 revenue of $2.58 billion, more than doubling year over year, with revenue backlog reaching approximately $104 billion.
• The company reported adjusted EBITDA of $1.51 billion, while GAAP net loss widened to about $626 million as infrastructure investment continued.
• AI cloud providers are expanding computing capacity through financing, customer partnerships, and specialized infrastructure while managing high capital requirements.

• Tapestry (NYSE:TPR) reported fiscal 2026 revenue of $8 billion, up 14%, as Coach revenue increased 24% for the year.
• Ralph Lauren is also posting double-digit growth, while Capri and LVMH’s Fashion & Leather Goods business show a more mixed sales picture.
• The sector now faces uneven consumer demand, tariffs, currency movements and pressure to protect margins while maintaining brand growth.

Tvardi Therapeutics (NASDAQ:TVRD) reported a Q2 2026 net loss of $6.5 million as R&D spending declined to $4 million.